Sensex Ends Marginally Higher; Energy And IT Stocks Witness Buying
After opening the day on a strong note, Indian share markets erased most of the gains and turned highly volatile in the afternoon session.
Benchmark indices erased gains during closing hours tracking weakness in banking and finance stocks.
Sectoral indices ended on a mixed note with stocks in the energy sector and IT sector witnessing buying interest.
Meanwhile, banking stocks witnessed selling pressure.
After rising more than 400 points in early trade, the BSE Sensex ended the day up by 99 points.
Meanwhile, the NSE Nifty stood higher by 47 points.
SGX Nifty was trading at 10,810, up by 39 points, at the time of writing.
The BSE Mid Cap index ended up by 0.1%. The BSE Small Cap index ended down by 0.2%.
Asian stock markets ended on a positive note today as stocks gained ignoring the global rise in coronavirus cases, giving more weight for expected government stimulus.
As of the most recent closing prices, the Hang Seng was up 0.2% and the Shanghai Composite stood higher by 1.8%. The Nikkei ended up by 2.2%.
European stock markets opened higher today as French and Italian industry output data rebounded more than expected in May.
Gold prices are trading up by 0.6% at Rs 49,149 per 10 grams.
The rupee is trading at 75.19 against the US$.
Market participants were tracking Avenue Supermarts' share price. Shares of the company declined over 5% today after the company reported an 88% fall in its net profit for the April-June quarter (Q1FY21).
Avenue Supermarts, the operator of hypermarket stores DMart, said that operations and financial performance during the quarter were hit by the lockdown. Revenues were down 32% from the previous year.
Consolidated total revenue for the hypermarket chain stood at Rs 39.3 billion in the June quarter, down from Rs 58.3 billion in the same quarter last year.
In news from the realty sector, shares of Omaxe were locked in a 5% down circuit at Rs 75.85, an 11-year low, despite the company issuing a clarification regarding the recent volatility in the stock price.
The real estate firm's stock was locked in lower circuit for 12th straight trading day today. The stock is trading at its lowest level since July 14, 2009.
Recently, the company had issued a clarification to the exchanges, saying the movement in the share price is purely due to market conditions and based on demand and supply principles.
According to the disclosure made by the company on Friday, July 10, lender Venus India Asset-Finance Private Limited has invoked 160,000 equity shares held by Guild Builders Private Limited, one of the promoters of Omaxe.
As on March 31, 2020, out of a total of 74.15% or 135.63 million equity shares held by promoters, about 52.32% or 70.97 million equity shares were pledged, the shareholding pattern data shows.
Omaxe, which was scheduled to announce its January-March quarter (Q4FY20) earnings on June 29, has postponed the same by a month.
On June 26, the company had informed the stock exchange that the board of directors of the company is now scheduled to meet on July 29, 2020, to approve the Q4 results.
The board will also consider and recommend dividend on preference shares and equity shares. It will also approve the enabling resolution for shareholder's approval to undertake fundraising activity.
Moving on, in the latest developments from the IPO space, after a four-month lull in the IPO market, Rossari Biotech's public issue opened for subscription today.
In the Rs 5 billion IPO, Rossari Biotech has fixed a price band of Rs 423-425 per equity share and the issue will remain open till July 15th.
Rossari Biotech's IPO comprises fresh issuance of shares worth Rs 500 million and sale of 1,05,00,000 equity shares by the company's promoters through offer-for-sale route. Post the IPO, the promoter shareholding will fall to 73% from 95% earlier.
Investors can bid in lot sizes of 35 shares. The equity shares will be listed on the NSE and BSE.
The net proceeds from the IPO will be utilized for funding working capital requirements, repaying certain debt availed by the company, and for general corporate purposes.
Rossari Biotech is a specialty chemical manufacturing firm with a focus on home and personal care, performance chemicals, textile specialty chemicals, and animal health and nutrition products.
At the time of writing, the issue had received bids for 27,58,560 shares, which was 34% of the issue size of 81,73,530 shares.
On Friday, the company raised Rs 1,488.7 million from anchor investors, who included top three fund houses - SBI Mutual Fund, HDFC Mutual Fund and ICICI Prudential Mutual Fund.
Are Retail Investors Back in the IPO Game?
Does this hint that retail investors are coming back to the markets? It would be interesting to see how this trend pans out in 2020.
Disclosure: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research ...
more